The Binding Site Group , Ltd.

The Binding Site Group , Ltd. — FDA 510(k) Submissions

The Binding Site Group , Ltd. has submitted 43 FDA 510(k) premarket notifications since 2010, of which 43 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Method, Nephelometric, Immunoglobulins (g, A, M), Kappa, Antigen, Antiserum, Control, Albumin, Antigen, Antiserum, Control, Immunoglobulin A Kappa Heavy & Light Chain Combined, System, Test, Rheumatoid Factor . Use the specialty filter in the sidebar to narrow results.